BridgeMD
New treatment option for Diabetes Mellitus, Type 2
Official title Postoperative Basal Bolus or Sliding Scale Insulin Regimen in DM2 and Its Effect on Surgical Site Infections.
ClinicalTrials.gov ID: NCT06638567
What this study is testing
- What it's testing
- A multicentre, matched-pair, cluster randomised controlled superiority trial to investigate the effect of a proactive basal bolus insulin regimen compared to the reactive sliding scale insulin regimen, targeting a glucose level of 3.9-10.0 mmol/L, to reduce the number of surgical site infections within the first 30 days postoperatively in adult patients with diabetes mellitus type 2.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients aged 18 or older
- Diagnosed with type 2 diabetes mellitus
- Undergoing gastointestinal or vascular surgery
- Admitted to one of the participating surgical wards
- Expected duration of stay at least one overnight stay
You likely can't join if
- Diagnosed with type 1 diabetes mellitus
- Female of child-bearing potential who is pregnant or breastfeeding.
- Undergoing complete pancreatectomy
- Undergoing bariatric surgery
- Patients using a continuous insulin pump at home
- Patients undergoing a necrotectomy/wound debridement from a pre-existent wound.
See the full eligibility criteria
- Patients aged 18 or older
- Diagnosed with type 2 diabetes mellitus
- Undergoing gastointestinal or vascular surgery
- Admitted to one of the participating surgical wards
- Expected duration of stay at least one overnight stay
- Willing and able to provide informed consent
- Diagnosed with type 1 diabetes mellitus
- Female of child-bearing potential who is pregnant or breastfeeding.
- Undergoing complete pancreatectomy
- Undergoing bariatric surgery
- Patients using a continuous insulin pump at home
- Patients undergoing a necrotectomy/wound debridement from a pre-existent wound.
The study team makes the final eligibility decision.
Where it's taking place
- Amsterdam, Netherlands
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Amsterdam, Netherlands. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.